Harnessing the Power of Technology to Transform Delirium Severity Measurement in the ICU

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this observational study is to develop a passive digital marker (PDM) for delirium severity and examine its performance in comparison to validated delirium severity tools in ICU patients \>50 years of age. The main questions it aims to answer are: * Is the trained convolutional neural network able to reliably measure delirium severity. * Is the Passive Digital Marker able to accurately measure delirium severity * Is the Passive Digital Marker acceptable and usable by frontline ICU nurse clinicians, patients, and their identified proxies (i.e., caregivers). Participants will: * Study participation involves a video camera recording you 24 hours per day while you are a patient in the Intensive Care Unit (ICU). * Study staff will visit you 4 times each day you are in the ICU. You will be asked questions each time they visit to train the digital marker and see differences between assessments and camera data.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: f
View:

• Estimated length of stay \>24 hours in ICU; and

• Are not admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal.

Locations
United States
Minnesota
Mayo Clinic
RECRUITING
Rochester
Contact Information
Primary
Heidi Lindroth, PH.D. R.N.
lindroth.heidi@mayo.edu
507-284-3662
Backup
Hannah Friesen
friesen.hannah@mayo.edu
1-507-284-2197
Time Frame
Start Date: 2023-01-15
Estimated Completion Date: 2026-12-18
Participants
Target number of participants: 400
Treatments
No Delirium Severity
Patients who did not experience a level of delirium severity (subsyndromal, mild, moderate, severe)
Delirium Severity
Patients who did experience a level of delirium severity (subsyndromal, mild, moderate, severe)
Related Therapeutic Areas
Sponsors
Leads: Mayo Clinic

This content was sourced from clinicaltrials.gov